Moneycontrol PRO
X

business

AstraZeneca Pharma, Themis Medicare, PG Electroplast, Shilpa Medicare in Focus | Stocks On Radar

Gujarat Themis Biosyn to merge with Themis Medicare. AstraZeneca Pharma to launch Breztri Aerosphere in January 2025 in India. Shilpa Medicare subsidiary receives certificate of suitability (CEP) from EDQM, for API, Octreotide. Shilpa Medicare subsidiary receives certificate of suitability (CEP) from EDQM, for API, Octreotide. PG Electroplast subsidiary signs definitive agreement with Spiro Mobility to manufacture electric vehicles of Spiro in India. Watch here for more details -

first published: Nov 19, 2024 11:45 am

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347